Brigitte Autran

Q: What Schools Are Affiliated With Brigitte Autran

Brigitte Autran is affiliated with the following schools: Université Paris Cité, Sorbonne University

Brigitte Autran's AcademicInfluence.com Rankings

Brigitte Autran

Philosophy

#8197

World Rank

#11530

Historical Rank

Logic

#5225

World Rank

#6608

Historical Rank

philosophy Degrees

Brigitte Autran

Biology

#11061

World Rank

#14436

Historical Rank

Immunology

#707

World Rank

#729

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Brigitte Autran's Degrees

Doctorate Medicine Université Paris Cité
PhD Immunology Université Paris Cité

Why Is Brigitte Autran Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Brigitte Autran's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. (1997) (1913)
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study (2013) (895)
Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover (2007) (747)
Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease (1998) (584)
AIDS virus-specific cytotoxic T lymphocytes in lung disorders (1987) (545)
Towards an HIV cure: a global scientific strategy (2012) (520)
Persistent Chronic Inflammation and Infection by Chikungunya Arthritogenic Alphavirus in Spite of a Robust Host Immune Response (2010) (506)
Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy (1998) (476)
SARS-CoV-2 variants and ending the COVID-19 pandemic (2021) (374)
International AIDS Society global scientific strategy: towards an HIV cure 2016 (2016) (372)
Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients (1996) (365)
Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. (2000) (342)
40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. (2006) (328)
Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. (1989) (303)
Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients (2006) (291)
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs (2013) (288)
A patient with HIV-1 superinfection. (2002) (263)
Accelerated immune senescence and HIV-1 infection (2007) (243)
Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. (2009) (242)
Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure (2015) (241)
HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes (1994) (227)
Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis. (2000) (224)
Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. (1999) (224)
A Dendritic Cell–Based Vaccine Elicits T Cell Responses Associated with Control of HIV-1 Replication (2013) (206)
Depletion in blood CD11c-positive dendritic cells from HIV-infected patients. (1999) (203)
HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group. (1999) (185)
PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status (2007) (176)
Sex Differences in Plasmacytoid Dendritic Cell Levels of IRF5 Drive Higher IFN-α Production in Women (2015) (164)
HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection (2001) (159)
HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis. (2011) (158)
Infection frequency of dendritic cells and CD4+ T lymphocytes in spleens of human immunodeficiency virus-positive patients (1995) (156)
Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients (2011) (149)
T cell receptor gamma/delta+ lymphocyte subsets during HIV infection. (1989) (148)
Oligoclonal expansion of CD8+ CD57+ T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation. (1994) (144)
Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody. (1990) (141)
Transient Mobilization of Human Immunodeficiency Virus (HIV)-Specific CD4 T-Helper Cells Fails To Control Virus Rebounds during Intermittent Antiretroviral Therapy in Chronic HIV Type 1 Infection (2001) (141)
Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction. (1989) (135)
Distinct Time Effects of Vaccination on Long-Term Proliferative and IFN-γ–producing T Cell Memory to Smallpox in Humans (2004) (133)
Escape from highly effective public CD8+ T-cell clonotypes by HIV. (2011) (133)
Therapeutic Vaccines for Chronic Infections (2004) (132)
Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer. (2018) (130)
A systematic comparison of methods to measure HIV-1 specific CD8 T cells. (2003) (130)
Restoration of the immune system with anti-retroviral therapy. (1999) (130)
Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo. (1996) (129)
Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection. (2005) (128)
Human immunodeficiency virus-related lymphocytic alveolitis. (1988) (127)
Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen. (1999) (126)
Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies (2009) (126)
AIDS IN A HAITIAN WOMAN WITH CARDIAC KAPOSI'S SARCOMA AND WHIPPLE'S DISEASE (1983) (125)
Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease (2005) (124)
Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes. (1989) (124)
Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression. (2005) (123)
Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma. (2006) (122)
HIV (2018) (122)
Expression of a mannose/fucose membrane lectin on human dendritic cells (1996) (120)
Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy. (2001) (119)
A therapeutic dendritic cell-based vaccine for HIV-1 infection. (2011) (116)
Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells. (2012) (113)
Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV (2005) (109)
A soluble factor released by CD8+CD57+ lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis. (1991) (106)
Elite controllers as a model of functional cure (2011) (105)
Monocyte‐derived dendritic cells have a phenotype comparable to that of dermal dendritic cells and display ultrastructural granules distinct from Birbeck granules (1998) (101)
Transcutaneous Anti-Influenza Vaccination Promotes Both CD4 and CD8 T Cell Immune Responses in Humans1 (2008) (100)
Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy (2001) (99)
Tuberculosis-Associated Immune Restoration Syndrome in HIV-1-Infected Patients Involves Tuberculin-Specific CD4 Th1 Cells and KIR-Negative γδ T Cells1 (2009) (99)
Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis. (1992) (98)
Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. (2001) (98)
High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease. (2004) (96)
Preferential Amplification of CD8 Effector-T Cells after Transcutaneous Application of an Inactivated Influenza Vaccine: A Randomized Phase I Trial (2010) (96)
Immune reconstitution after a decade of combined antiretroviral therapies for human immunodeficiency virus. (2011) (94)
Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission. (2015) (93)
Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection (2002) (93)
Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452) (2008) (92)
A Th0/Th2-like function of CD4+CD7- T helper cells from normal donors and HIV-infected patients. (1995) (92)
Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patients. (1988) (90)
CD4+CD7-CD57+ T cells: a new T-lymphocyte subset expanded during human immunodeficiency virus infection. (1992) (87)
A lectin‐binding soluble factor released by CD8+CD57+ lymphocytes from AIDS patients inhibits T cell cytotoxicity (1991) (87)
HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression. (2001) (86)
Yeast-Derived Human Immunodeficiency Virus Type 1 p55gag Virus-Like Particles Activate Dendritic Cells (DCs) and Induce Perforin Expression in Gag-Specific CD8+ T Cells by Cross-Presentation of DCs (2003) (86)
INTERLEUKIN-2 ACCELERATES CD4 CELL RECONSTITUTION IN HIV-INFECTED PATIENTS WITH SEVERE IMMUNOSUPPRESSION DESPITE HIGHLY ACTIVE ANTIRETROVIRAL THERAPY: THE ILSTIM STUDY—ANRS 082 (2002) (84)
CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity. (1998) (84)
Dynamics of HIV-Specific CD8+ T Lymphocytes with Changes in Viral Load1 (2000) (83)
High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma (2000) (81)
Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity (2006) (81)
Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus (2009) (78)
Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets (2011) (75)
A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis (2012) (75)
An inhibitor of cytotoxic functions produced by CD8+CD57+ T lymphocytes from patients suffering from AIDS and immunosuppressed bone marrow recipients (1994) (70)
Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir (2016) (70)
HIV-specific T Cell Cytotoxicity Mediated by RANTES Via the Chemokine Receptor CCR3 (1998) (68)
Status of long‐term asymptomatic HIV‐1 infection correlates with viral load but not with virus replication properties and cell tropism (1999) (68)
Immunogenicity of Mutations Induced by Nucleoside Reverse Transcriptase Inhibitors for Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Cells (2000) (68)
A Single HIV-1 Cluster and a Skewed Immune Homeostasis Drive the Early Spread of HIV among Resting CD4+ Cell Subsets within One Month Post-Infection (2013) (68)
Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway. (1990) (66)
Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab. (2017) (64)
Single DermaVir Immunization: Dose-Dependent Expansion of Precursor/Memory T Cells against All HIV Antigens in HIV-1 Infected Individuals (2012) (63)
Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression. (2016) (63)
Ultra-Protective Ventilation Reduces Biotrauma in Patients on Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. (2019) (63)
Minocycline-induced cell-mediated hypersensitivity pneumonitis. (1992) (62)
Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups. (2000) (62)
Safety and immunogenicity of a live recombinant canarypox virus expressing HIV type 1 gp120 MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV infection (1999) (62)
Defective p56Lck activity in T cells from an adult patient with idiopathic CD4+ lymphocytopenia. (2000) (61)
Boosting Immunity to HIV--Can the Virus Help? (2000) (61)
Human trophoblast cells express CD4 and are permissive for productive infection with HIV‐1 (1992) (60)
T cell changes after combined nucleoside analogue therapy in HIV primary infection. (1999) (59)
Evolution and plasticity of CTL responses against HIV. (1996) (59)
Bioterrorism: management of major biological agents. (2006) (59)
The chemokine receptor CX3CR1 controls homing and anti‐viral potencies of CD8 effector‐memory T lymphocytes in HIV‐infected patients (2003) (59)
HIV-1 infection of lung alveolar fibroblasts and macrophages in humans. (1990) (57)
Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study (2014) (57)
Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS (2009) (57)
CD4+Ki67+ lymphocytes in HIV‐infected patients are effector T cells accumulated in the G1 phase of the cell cycle (2000) (56)
Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication (2005) (55)
Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure. (2001) (55)
Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation (2017) (54)
Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial (2016) (53)
Severe herpes virus (HSV-2) infection in two patients with myelodysplasia and undetectable NK cells and plasmacytoid dendritic cells in the blood. (2004) (52)
Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapy. (2014) (51)
Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094). (2005) (51)
HIV-Infected Spleens Present Altered Follicular Helper T Cell (Tfh) Subsets and Skewed B Cell Maturation (2015) (51)
Immune interventions in HIV infection (2013) (51)
Differential Impact of Age and Cytomegalovirus Infection on the γδ T Cell Compartment (2013) (50)
Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus. (2011) (50)
Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy (2010) (49)
Reduced Oxidative Burst by Primed Neutrophils in the Elderly Individuals Is Associated With Increased Levels of the CD16bright/CD62Ldim Immunosuppressive Subset (2017) (48)
T-cell subset counting and the fight against AIDS: reflections over a 20-year struggle. (2002) (48)
Characterization of human immunodeficiency virus type 1 vif gene in long-term asymptomatic individuals. (2000) (48)
Long-term nonprogressors and elite controllers in the ANRS CO5 HIV-2 cohort (2011) (45)
rIL 2-induced proliferation of human circulating NK cells and T lymphocytes: synergistic effects of IL 1 and IL 2. (1987) (45)
Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first‐line combination antiretroviral therapy (2015) (45)
CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef. (1995) (45)
Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cells. (2008) (45)
Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients (2009) (44)
Cytotoxic T‐cell responses to HIV‐1 reverse transcriptase, integrase and protease (1998) (43)
Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccine (2011) (43)
Immune recognition of AIDS virus antigens by human and murine cytotoxic T lymphocytes. (1988) (43)
Detection of apoptosis at the single-cell level by direct incorporation of fluorescein-dUTP in DNA strand breaks. (1996) (42)
Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation. (2009) (42)
Low CD83, but normal MHC class II and costimulatory molecule expression, on spleen dendritic cells from HIV+ patients. (1998) (42)
Identical Strength of the T Cell Responses against E2, nsP1 and Capsid CHIKV Proteins in Recovered and Chronic Patients after the Epidemics of 2005-2006 in La Reunion Island (2013) (41)
Alveolar CD8+CD57+ lymphocytes in human immunodeficiency virus infection produce an inhibitor of cytotoxic functions. (1994) (41)
Multiple subsets of HIV‐specific cytotoxic T lymphocytes in humans and in mice (1989) (41)
Registration of clinical trials. (2005) (41)
Neutrophils in antiretroviral therapy-controlled HIV demonstrate hyperactivation associated with a specific IL-17/IL-22 environment. (2014) (40)
Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group. (2016) (39)
Strong CD4 Th1 responses to HIV and hepatitis C virus in HIV-infected long-term non-progressors co-infected with hepatitis C virus (2002) (39)
Differential requirement of caspases during naive T cell proliferation (2002) (38)
HIV infection of choriocarcinoma cell lines derived from human placenta: the role of membrane CD4 and Fc-Rs into HIV entry. (1995) (38)
A triple-mutated allele of granzyme B incapable of inducing apoptosis (2003) (38)
HIV-specific effector cytotoxic T lymphocytes and HIV-producing cells colocalize in white pulps and germinal centers from infected patients. (2001) (37)
CTL Escape Mediated by Proteasomal Destruction of an HIV-1 Cryptic Epitope (2011) (37)
Blimp-1 overexpression is associated with low HIV-1 reservoir and transcription levels in central memory CD4+ T cells from elite controllers (2014) (37)
ACQUIRED IMMUNODEFICIENCY SYNDROME AFTER TRAVELLING IN AFRICA: AN EPIDEMIOLOGICAL STUDY IN SEVENTEEN CAUCASIAN PATIENTS (1987) (37)
Trapping and apoptosis of novel subsets of memory T lymphocytes expressing CCR6 in the spleen of HIV-infected patients. (2007) (36)
Cell-Mediated Immune Responses to COVID-19 Infection (2020) (35)
Late CD8+ lymphocytic alveolitis after allogeneic bone marrow transplantation and chronic graft-versus-host disease. (1994) (34)
Comprehensive Mass Cytometry Analysis of Cell Cycle, Activation, and Coinhibitory Receptors Expression in CD4 T Cells from Healthy and HIV‐Infected Individuals (2017) (34)
Up‐regulation of adhesion and MHC molecules on splenic monocyte/macrophages in adult haemophagocytic syndrome (1999) (33)
HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses (2015) (33)
NYVAC immunization induces polyfunctional HIV‐specific T‐cell responses in chronically‐infected, ART‐treated HIV patients (2012) (33)
Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia (2016) (32)
IL-2 therapy and thymic production of naive CD4 T cells in HIV-infected patients with severe CD4 lymphopenia (2003) (32)
Primary Th1 cell immunization against HIVgp160 in SCID-hu mice coengrafted with peripheral blood lymphocytes and skin. (1998) (32)
Low infection frequency of macrophages in the spleens of HIV+ patients. (1996) (32)
Idiopathic CD 4 Lymphocytopenia Clinical and Immunologic Characteristics and Follow-Up of 40 Patients (2014) (32)
Therapeutic vaccines against HIV need international partnerships (2003) (32)
Consistency of routine measurements of CD4+, CD8+ peripheral blood lymphocytes. (1992) (31)
Single-nucleotide polymorphism-defined class I and class III major histocompatibility complex genetic subregions contribute to natural long-term nonprogression in HIV infection. (2012) (31)
Effects of antiretroviral therapy on immune reconstitution. (1999) (31)
In vivo role of IL-6 on the viral load and on immunological abnormalities of HIV-infected patients. (1996) (31)
Effect of therapeutic intensification followed by HIV DNA prime and rAd5 boost vaccination on HIV-specific immunity and HIV reservoir (EraMune 02): a multicentre randomised clinical trial. (2015) (31)
Idiopathic CD4 Lymphocytopenia (2014) (31)
PD-1 blockade in HIV-infected patients with lung cancer: a new challenge or already a strategy? (2018) (30)
HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection (2017) (30)
Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial. (2012) (29)
Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-alpha and nitric oxide synthase. (2000) (29)
Characterization of pandemic influenza immune memory signature after vaccination or infection. (2014) (28)
Disease progression due to dual infection in an HLA-B57-positive asymptomatic long-term nonprogressor infected with a nef-defective HIV-1 strain. (2010) (28)
Cell permeabilization for the assessment of T lymphocyte polyfunctional capacity. (2007) (28)
[Antiretroviral therapy and immune reconstitution]. (1999) (28)
Evaluation of the Interlaboratory Concordance in Quantification of Human Immunodeficiency Virus-Specific T Cells with a Gamma Interferon Enzyme-Linked Immunospot Assay (2006) (28)
Wild type and H43Y variant of human TRIM5α show similar anti-human immunodeficiency virus type 1 activity both in vivo and in vitro (2007) (28)
Structural constraints of HIV-1 Nef may curtail escape from HLA-B7-restricted CTL recognition. (1997) (27)
Transfer of Human CD4+ T Lymphocytes Producing Beta Interferon in Hu-PBL-SCID Mice Controls Human Immunodeficiency Virus Infection (1999) (27)
Evidence for naive T-cell repopulation despite thymus irradiation after autologous transplantation in adults with multiple myeloma: role of ex vivo CD34+ selection and age. (2003) (27)
Interferon beta transduction of peripheral blood lymphocytes from HIV-infected donors increases Th1-type cytokine production and improves the proliferative response to recall antigens. (1997) (27)
Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients (2013) (27)
Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector/memory CD4+ lymphocytes in humans. (2010) (27)
Treatment interruption after one year of triple nucleoside analogue therapy for primary HIV infection. (2001) (27)
No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia (1998) (26)
Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group. (1999) (26)
Polyfunctional HIV-specific T cells in Post-Treatment Controllers. (2016) (25)
Safety and immunogenicity of a recombinant HIV type 1 glycoprotein 160 boosted by a V3 synthetic peptide in HIV-negative volunteers. (1995) (25)
Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells (2009) (25)
Immune reconstitution after highly active anti-retroviral treatment of HIV infection. (2001) (25)
Expansion of CD4+CD7- T cells, a memory subset with preferential interleukin-4 production, after bone marrow transplantation. (1997) (24)
Expansion of Human Cytomegalovirus (HCMV) Immediate-Early 1-Specific CD8+ T Cells and Control of HCMV Replication after Allogeneic Stem Cell Transplantation (2008) (24)
A monoclonal antibody stands out against omicron subvariants: a call to action for a wider access to bebtelovimab (2022) (24)
A Novel Mode of Human Immunodeficiency Virus Type 1 (HIV-1) Activation: Ligation of CD28 Alone Induces HIV-1 Replication in Naturally Infected Lymphocytes (1993) (24)
B-cell pulmonary lymphoma: gene rearrangement analysis of bronchoalveolar lymphocytes by polymerase chain reaction. (1999) (23)
Thymocyte and thymic microenvironment alterations during a systemic HIV infection in a severe combined immunodeficient mouse model (1996) (23)
Arthralgias and cryoglobulinemia during protease inhibitor therapy in a patient infected with human immunodeficiency virus and hepatitis C virus. (1998) (23)
Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection. (2014) (23)
The V1V2 Domain and an N-Linked Glycosylation Site in the V3 Loop of the HIV-1 Envelope Glycoprotein Modulate Neutralization Sensitivity to the Human Broadly Neutralizing Antibody 2G12 (2011) (23)
Separation of Mononuclear Bone Marrow Cells using the Cobe 2997 Blood Cell Separator (1988) (23)
HIV-1 and SIV Predominantly Use CCR5 Expressed on a Precursor Population to Establish Infection in T Follicular Helper Cells (2017) (22)
EVIDENCE THAT RESIDUAL HOST CELLS SURVIVING THE CONDITIONING REGIMEN TO ALLOGENEIC BONE MARROW TRANSPLANTATION INHIBIT DONOR HEMATOPOIESIS IN VITRO—THE ROLE OF TNF-α (1991) (22)
MHC-restricted cytotoxicity against HIV. (1991) (22)
CD8 lymphocytosis and pseudotumoral splenomegaly in HIV infection (1992) (22)
Distinct differentiation profiles of HIV-Gag and Nef-specific central memory CD8+ T cells associated with HLA-B57/5801 and virus control (2010) (21)
Immunodeficiency in HIV infection and AIDS (1992) (21)
The HIV infection and immune activation: ‘To fight and burn’ (2005) (21)
Characteristics of the env Genes of HIV Type 1 Quasispecies in Long-Term Nonprogressors With Broadly Neutralizing Antibodies (2008) (21)
Anti-PGL-Tb1 responses as an indicator of the immune restoration syndrome in HIV-TB patients. (2008) (21)
Pulmonary infections associated with systemic capillary leak syndrome attacks in a patient with hypogammaglobulinemia (1998) (21)
Dynamics in HIV‐DNA levels over time in HIV controllers (2019) (21)
Proliferative, IFNγ and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection (2006) (21)
Antigen‐specific proliferative human T cell clones with specificity for diphtheria toxoid: genetic and molecular restriction by class II antigens (1984) (20)
Influence of antigen exposure on the loss of long-term memory to childhood vaccines in HIV-infected patients. (2009) (20)
Leukemic CD3+ LGL share functional properties with their CD8+CD57+ cell counterpart expanded after BMT (1999) (20)
HIV-specific cytotoxic T lymphocytes directed against alveolar macrophages in HIV-infected patients. (1990) (20)
A simplified flow cytometry method of CD4 and CD8 cell counting based on thermoresistant reagents: Implications for large scale monitoring of HIV‐infected patients in resource‐limited settings (2005) (20)
Dynamics of HIV variants and specific cytotoxic T-cell recognition in nonprogressors and progressors. (1997) (20)
The SCID mouse mutant: definition and potential use as a model for immune and hematological disorders. (1997) (19)
A novel mode of human immunodeficiency virus type 1 (HIV-1) activation: ligation of CD28 alone induces HIV-1 replication in naturally infected lymphocytes (1993) (19)
HIV-specific cytotoxic T lymphocytes against alveolar macrophages: specificities and downregulation. (1991) (19)
Profound and possibly primary "idiopathic CD4+ T lymphocytopenia" in a patient with fungal infections. (1994) (18)
Immune checkpoint inhibitors in people living with HIV: what about anti-HIV effects? (2020) (18)
CMV driven CD8(+) T-cell activation is associated with acute rejection in lung transplantation. (2013) (18)
Decreased frequencies of virus-specific T helper type 1 cells during interferon alpha plus ribavirin treatment in HIV–hepatitis C virus co-infection (2003) (17)
Evaluating therapeutic vaccines in patients infected with HIV (2004) (17)
HIV epitopes recognized by cytotoxic T-lymphocytes. (1991) (17)
Markov modelling of changes in HIV‐specific cytotoxic T‐lymphocyte responses with time in untreated HIV‐1 infected patients (2003) (17)
Restoration of anti‐tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudy (2008) (17)
LYMPHADENOPATHY SYNDROME AND SEROCONVERSION TWO MONTHS AFTER SINGLE USE OF NEEDLE SHARED WITH AN AIDS PATIENT (1986) (16)
Increased carotid intima–media thickness is not associated with T-cell activation nor with cytomegalovirus in HIV-infected never-smoker patients (2015) (16)
Immune control of HIV-1 reservoirs (2013) (16)
The tyrosine kinase inhibitor Dasatinib blocks in-vitro HIV-1 production by primary CD4+ T cells from HIV-1 infected patients (2014) (16)
Changes in T-cell subsets in HIV–HCV-coinfected patients during pegylated interferon-α2a plus ribavirin treatment (2010) (16)
Clonal expansion of T cells and HIV genotypes in microdissected splenic white pulps indicates viral replication in situ and infiltration of HIV-specific cytotoxic T lymphocytes. (1995) (15)
Expansion of CD4+CD7- T helper cells with a TH0-TH2 function in kidney transplant recipients. (1995) (15)
HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial (2019) (15)
T lymphocyte subsets in primary antiphospholipid syndrome. (1994) (15)
Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death. (2020) (15)
Immune response to diphtheria toxin and to different CNBr fragments: Evidence for different B and T cell reactivities (1986) (15)
Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status (2017) (15)
Negative result of cytomegalovirus blood culture with restoration of CD4+ T-cell reactivity to cytomegalovirus after HAART in an HIV-1-infected patient. (1999) (14)
iNKT and memory B-cell alterations in HHV-8 multicentric Castleman disease. (2017) (14)
Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients (2018) (13)
T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individuals (2007) (13)
MHC-driven HIV-1 control on the long run is not systematically determined at early times post-HIV-1 infection (2013) (13)
Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years (2022) (13)
Perspectives for immunotherapy: which applications might achieve an HIV functional cure? (2016) (13)
HIV-1 therapeutic vaccines. (2002) (12)
Management of Multidrug-Resistant CMV Infection in Immunocompromised Patients: Case Report of a Heart-Transplant Recipient and Review of the Literature (2015) (12)
Toward a cure for HIV—Seeking effective therapeutic vaccine strategies (2015) (12)
Oligoclonal Expansion of CD 8 + CD 57 + T Cells With Restricted T-cell Receptor / 3 Chain Variability After Bone Marrow Transplantation (2002) (12)
Direct Quantification of Cell-Associated HIV DNA in Isolated Rectal and Blood Memory CD4 T Cells Revealed Their Similar and Low Infection Levels in Long-Term Treated HIV-Infected Patients (2013) (12)
Maraviroc does not affect humoral response to the pandemic influenza A-H1N1v 2009 adjuvanted vaccine in HIV-1-infected patients (2010) (12)
A prospective national cohort evaluating ring MVA vaccination as post-exposure prophylaxis for monkeypox (2022) (12)
Analysis by flow cytometry of tyrosine-phosphorylated proteins in activated T-cell subsets on whole blood samples. (1997) (12)
Studies of T cell reconstitution after hematopoietic stem cell transplant. (1997) (12)
Imbalanced "memory" T lymphocyte subsets and analysis of dendritic cell precursors in the peripheral blood of adult patients with Langerhans cell histiocytosis. (1997) (11)
The Quest Trial, a paradigm of HIV collaborative research (2000) (11)
Lack of TGF-β production by hepatitis C virus-specific T cells during HCV acute phase is associated with HCV clearance in HIV coinfection. (2012) (11)
Preservation of immune function and anti-hepatitis C virus (HCV) immune responses after liver transplantation in HIV-HCV coinfected patients (ANRS-HC08 "THEVIC" trial). (2009) (11)
Activated CD8+ Cells in HIV-Related Diseases (1992) (11)
The Th1 immune response against HIV‐1 Gag p24‐derived peptides in mice expressing HLA‐A02.01 and HLA‐DR1 (2007) (10)
[Decrease of erythrocyte receptors for the C3b fragment of complement in acquired immunodeficiency syndrome]. (1988) (10)
Disseminated Mycobacterium avium intracellulare infection without predisposing conditions (1992) (10)
Intratumoral activation of CD8-positive cytotoxic lymphocytes in acquired immunodeficiency syndrome lymphomas. (1995) (10)
HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort) (2019) (9)
The link between CD8+ T-cell antigen-sensitivity and HIV-suppressive capacity depends on HLA restriction, target epitope and viral isolate (2014) (9)
Polymorphism in the proximal promoter region of the perforin gene and its impact on the course of HIV infection (2006) (9)
Acquired constitutive expression of interferon beta after gene transduction enhances human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity by a RANTES-dependent mechanism. (1999) (9)
Dose-dependent systemic human immunodeficiency virus infection of SCID-hu mice after intraperitoneal virus injection. (1995) (8)
25 Years of AIDS: recording progress and future challenges. (2012) (8)
Risk of HIV transmission during combined ART initiation for HIV-infected persons with severe immunosuppression (2017) (8)
[Deficiency of the CD3-TCR signal pathway in three patients with idiopathic CD4+ lymphocytopenia]. (1999) (8)
Therapeutic immunization in HIV infection (2006) (8)
Barriers to a Cure: New concepts in targeting and eradicating HIV-1 reservoirs (2013) (8)
P16-17. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV suppressive activity (2009) (8)
HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects (2016) (8)
Persistent COVID-19 in an immunocompromised host treated by SARS-CoV-2-specific monoclonal antibodies (2021) (8)
T Cells Subtypes in a Patient With Interferon-&agr; Induced Sarcoidosis (2009) (7)
In Vivo Priming Of HIV-Specific CTLs Determines Selective Cross-Reactive Immune Responses Against Poorly Immunogenic HIV-Natural Variants1 (2002) (7)
Switch to maraviroc/raltegravir dual therapy leads to an unfavorable immune profile with low-level HIV viremia (2015) (7)
What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM (2017) (7)
Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection (2019) (7)
Increase of HIV-1 Pro-Viral Dna per Million Peripheral Blood Mononuclear Cells in Patients with Advanced HIV Disease (Cd4<200 Cells/Mm3) Receiving Interleukin 2 Combined with Haart Versus Haart Alone (Anrs-082 Trial) (2002) (7)
Demographic and Clinical Factors Associated with Response to Smallpox Vaccine in Preimmunized Volunteers (2008) (7)
Lymphocytic alveolitis after primary HIV infection with CMV coinfection. (1997) (7)
Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH). (2020) (7)
SCID-Hu mouse as a model for human lung HIV-1 infection. (1994) (7)
Cytotoxic T-Lymphocyte Responses to HIV (1996) (6)
A step ahead on the HIV collaboratory. (2009) (6)
Clinical and laboratory findings of acute Zika virus infection in patients from Salvador during the first Brazilian epidemic (2020) (6)
CD 4 + CD 7-CD 57 + T Cells : A New T-Lymphocyte Subset Expanded During Human Immunodeficiency Virus Infection (2003) (6)
Serum Tryptophan-Derived Quinolinate and Indole-3-Acetate Are Associated With Carotid Intima-Media Thickness and its Evolution in HIV-Infected Treated Adults (2019) (6)
Maraviroc-induced decrease in circulating bacterial products is not linked to an increase in immune activation in HIV-infected individuals. (2013) (6)
Three-Year Immune Reconstitution in PI-Sparing and PI-Containing Antiretroviral Regimens in Advanced HIV-1 Disease (2007) (6)
A T chronic lymphocytic leukemia with large granular lymphocytes phenotype and functions of leukemic cells under in vitro treatment by differentiation inducers (1987) (5)
Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer (2022) (5)
Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals. (2017) (5)
No influence of human herpesvirus 8 infection on the progression of HIV‐1 infection in initially asymptomatic patients (2003) (5)
Distinct immunopathological mechanisms of EBV‐positive and EBV‐negative posttransplant lymphoproliferative disorders (2021) (5)
[Cytotoxic T cells against HIV]. (1990) (5)
Erratum: (Retracted article): Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-α and nitric oxide synthase (AIDS (2002) 14 (827-838)) (2004) (5)
Biological weapons (2006) (5)
Monoclonal B-cell response to diphtheria toxoid: evidence for cross-reactive epitopes. (1987) (5)
Splenic interdigitating dendritic cells in humans: characterization and HIV infection frequency in vivo. (1995) (5)
Skewed T cell responses to Epstein-Barr virus in long-term asymptomatic kidney transplant recipients (2019) (4)
[Lymphocytic alveolitis in the early stages of HIV infection: correlation with biological and prognostic factors]. (1992) (4)
Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1–positive individuals (2020) (4)
S03-04 OA. Transitional and central memory CD4 T cells are highly infected in long term non progressors and elite controllers (2009) (4)
Host Defenses against Viral Infection (2002) (4)
Strategies toward restoration of immunity to HIV. (2002) (4)
Antibodies raised against peptide fragments of CD16 reacting with membrane and soluble form of CD16. I: Production and characterization. (1992) (3)
Vaccination in HIV-infected individuals (2012) (3)
Decreased peripheral circulation of HIV-infected cells in a subset of long-term nonprogressors. The French ALT Study Group. (1999) (3)
Interferon b transduction of peripheral blood lymphocytes from HIV-infected donors increases Th1-type cytokine production and improves the proliferative response to recall antigens (gene therapyyretroviral vectoryhuman CD41 cellsyimmunology) (1997) (3)
[Evaluation of residual immune response against human pox virus before and after revaccination in healthy volunteers]. (2006) (3)
Effect of lentivirus encoding HIV-1 Nef-U3 shRNA on the function of HIV-specific memory CD4+ T cells in patients with chronic HIV-1 infection (2009) (3)
EFFECT OF TRICYCLIC ANTIDEPRESSANTS ON LYSOSOMAL SPHINGOMYELINASE ACTIVITY (1988) (3)
T Cells δγ and KIR-Negative Involves Tuberculin-Specific CD 4 Th 1 Cells Syndrome in HIV-1-Infected Patients Tuberculosis-Associated Immune Restoration Autran (2009) (3)
Hepatitis C virus infection in long-term nonprogressor HIV-1-infected subjects. (2002) (3)
Extensive uORF translation from HIV-1 transcripts conditions DDX3 dependency for expression of main ORFs and elicits specific T cell immune responses in infected individuals (2022) (3)
Plasticity of lymphoid compartments during HIV infection and treatments: hopes and limits. (2002) (3)
Low-Coverage Whole Genome Sequencing of Cell-Free DNA From Immunosuppressed Cancer Patients Enables Tumor Fraction Determination and Reveals Relevant Copy Number Alterations (2021) (3)
Initiating Antiretroviral Treatment Early in Infancy Has Long-term Benefits on the Human Immunodeficiency Virus Reservoir in Late Childhood and Adolescence. (2021) (3)
Reply to Immunometabolism may provide insights into novel mechanisms of HIV reservoir persistence. (2016) (3)
Additional mutations detected in sequential HIV‐1 isolates from ZDV‐treated patients (1997) (3)
Immune Reconstitution of the CD4 T‐Cell Compartment in HIV Infection (2001) (3)
[Flow cytometry: principles and main applications]. (1985) (2)
Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial). (2016) (2)
Cynomolgus macaque IL37 polymorphism and control of SIV infection (2019) (2)
Will the immune system ever recover? (1999) (2)
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial (2023) (2)
[Anti-I anti-erythrocyte auto-immunization in malaria]. (1984) (2)
T-cell depletion of bone marrow transplants: assessment of standard immunological methods of quantification. (1987) (2)
Evaluation of the protective effect of human cytotoxic lymphocytes (CTL) specific for P210BCR-ABL protein in a SCID mouse model (1998) (2)
[Immunologic reconstruction after antiretroviral treatment]. (1999) (2)
Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiation (2022) (2)
[Inhibitor effect of CD8+CD57+ lymphocytes on cell-mediated cytotoxicity: characterization of suppressor factor]. (1991) (2)
HCV drives increased type I IFN-associated impairments associated to fibrosis severity in ART-treated HIV-1-HCV coinfected individuals. (2017) (2)
human immunodeficiency virus infection CD4+CD7-CD57+ T cells: a new T-lymphocyte subset expanded during (2011) (2)
[Biological follow-up of patients with HIV treated with anti-PD-1 or anti-PD-L1 for non-small cell bronchial carcinoma: A task group proposal]. (2016) (2)
A comparison of cell activation, exhaustion and expression of HIV co-receptors and restriction factors in HIV-1 and HIV-2 infected Non Progressors. (2020) (2)
Extremely severe CD4 lymphopenia during HIV-1 primary infection. (2019) (1)
Severe idiopathic CD4 lymphocytopenia: Biochemical and functional studies reveal different CD4 T cell defects in two patients (1997) (1)
Responses in Humans Promotes Both CD 4 and CD 8 T Cell Immune Transcutaneous Anti-Influenza Vaccination (2008) (1)
Retraction. Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-alpha and nitric oxide synthase. (2004) (1)
Dynamics of HIV variants and specific CTL recognition in nonprogressors (1997) (1)
[Pancreatic islet transplantation: isolation techniques and in vitro immunomodulation]. (1996) (1)
[Update on smallpox vaccines]. (2004) (1)
[Alterations in responses to vaccines in older people]. (2019) (1)
[Recurrent facial edema disclosing lymph node T-cell lymphoma]. (1995) (1)
Anti-retroviral therapies in advanced patients can restore CD4 T cell functions (1997) (1)
[Acute cardiac graft rejection after orthotopic cardiac transplantation. Elements of diagnosis and monitoring, therapeutic attitude]. (1992) (1)
A Soluble Inhibitor of Cytotoxic Functions (1992) (1)
Cytotoxic T Lymphocytes in HIV-1 Infection (2000) (1)
T-cell-mediated cytotoxicity against HIV in seropositive patients: a physiopathological approach. (1989) (1)
Characterization of the CD4 TH1 and CD8 responses against hepatitis C virus and HIV in peripheral blood of HCV-HIV coinfected patients (2001) (1)
Bridging the Gaps between Fundamental, Preclinical and Clinical Research: Report from a Global HIV Vaccine Enterprise Working Group (2010) (1)
Compartment T Cell δγ Cytomegalovirus Infection on the Differential Impact of Age and Appay (2013) (1)
Gene Rearrangement Analysis of Bronchoalveolar Lymphocytes by Polymerase Chain Reaction (2015) (1)
Distinct antibody profiles in HLA-B∗57+, HLA-B∗57− HIV controllers and chronic progressors (2021) (1)
[Pseudo-mycosis fungoides T-lymphoma associated with an HTLV retrovirus in an African]. (1984) (1)
HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data) (2022) (1)
[Recurrent erythema multiforme associated with hypogammaglobulinemia of variable expression]. (1990) (1)
reveals evidence of in vivo activation in a subset of organ donors Investigation of human spleen dendritic cell phenotype and distribution (2013) (1)
Track A Basic Science (2012) (1)
Memory CD4+ T-Cell Lymphocytic Angiopathy in Fatal Forms of COVID-19 Pulmonary Infection (2022) (1)
Comprehensive mass cytometry analysis of cell cycle, activation and co‐inhibitory receptors expression in CD4 T cells from healthy and HIV‐infected individuals (2017) (1)
Anticorps anticardiolipines, réplication virale, anticorps neutralisants et activation immune chez les patients VIH asymptomatiques à long terme (2009) (0)
Lymphocytes with Changes in Viral Load T + Dynamics of HIV-Specific CD8 (2014) (0)
Tackling latency as a barrier to an HIV cure: what next? (2015) (0)
Adaptations of CTL responses to drug-induced variants of HIV-1 reverse transcriptase (1997) (0)
In vitro immunomodulation of human islet allografts using mixed islet lymphocyte coculture. (1997) (0)
OPINION Immune control of HIV-1 reservoirs (2013) (0)
[The French Committee for the prevention and control of influenza and the 2009 influenza pandemic: Lessons learnt]. (2012) (0)
[Recurrent meningococcal meningitis associated with complement C6 deficiency (author's transl)]. (1981) (0)
[Amplification of a circulating CD4+CD7- T lymphocytes subset in kidney transplantation]. (1992) (0)
Human immunodeficiency virus-specific T lymphocyte cell (2001) (0)
[Viral reservoir in HIV-2 infection: a model for attenuated retroviral infection]. (2020) (0)
Cynomolgus macaque IL37 polymorphism and control of SIV infection (2019) (0)
Reply to Spellberg (2006) (0)
[Vaccination: recall or second dose, semantic difference or immunologic reality?]. (2005) (0)
Low to undetectable Omicron BQ.1.1 neutralization by patient’s sera a month after initiation of AZD7442 600mg (2023) (0)
One Step Closer to HIV Eradication? (2014) (0)
Is lymphocyte transfer a promising therapeutic approach towards AIDS? (1987) (0)
[Development of an anti-HIV gene therapy based on the antiviral properties of beta interferon]. (1997) (0)
P04-17. The N-glycosylation sites N295, N332 and N392 of gp120 are necessary but not sufficient for HIV-1 to be neutralized by 2G12 (2009) (0)
[Control of cytotoxic T cell responses]. (1992) (0)
Dynamics of the CD8 cytotoxic T cell differentiation and activation with HIV burden and anti-retroviral therapy (1997) (0)
Immune reconstitution in HIV infection (2004) (0)
Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH) (2022) (0)
A new HHV-8+ EBV - B cell line (ISI-1) produces large amounts of IL10 and induces tumors in NOD/SCID mice (1998) (0)
miRNA 1479-5876-9-44 (2016) (0)
Lymphopénie CD4 idiopathique : suivi à long terme d’une cohorte de 36 patients (2012) (0)
Alveolar Cytotoxic T Lymphocytes Specific for HIV in HIV-Related Lung Diseases (1992) (0)
[HIV controllers: a new evolutionary entity of HIV infection?]. (2008) (0)
Identification of Autoreactive Human Bone Marrow and Peripheral Blood CD3−, CD4−, CD8−Prothymocytes (1989) (0)
Cannabis Use and Plasma Human Immunodeficiency Virus (HIV) RNA Levels in Patients Coinfected With HIV and Hepatitis C Virus Receiving Antiretroviral Therapy: Data From the ANRS CO13 HEPAVIH Cohort (2020) (0)
[Coronary pathology after heart transplantation]. (1992) (0)
Sub-populations of human spleen dendritic cells characterized by flow cytometry and in situ immunofluorescence (1997) (0)
A truncated HIV Tat demonstrates potent and specific latency reversal activity (2023) (0)
Immunogenicity of a BNT162b2 Vaccine Booster Against SARS-CoV-2 Delta and Omicron Variants in Older People (2022) (0)
Felipe García Control of HIV-1 Replication Based Vaccine Elicits T Cell Responses Associated with − A Dendritic Cell (2012) (0)
[Acute intoxication with beer. Water-electrolyte disturbances]. (1980) (0)
A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults (2022) (0)
[Prolonged treatment with thalidomide in a patient with HIV infection]. (1995) (0)
Immunological studies on the french cohort of 111 HIV-1 infected long-term non progressors (LT-NP) (1997) (0)
[175] SPECIFIC ANTI-HCV IMMUNE RESPONSES AFTER LIVER TRANSPLANTATION IN HIV/HCV CO-INFECTED PATIENTS (2007) (0)
HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial (2019) (0)
Human Immunodeficiency Virus (2004) (0)
Do integrase inhibitors affect immune restoration? (2020) (0)
Cellular immune responses and changes in VL after a Dendritic Cells (DC)-based therapeutic vaccine in cART treated chronic HIV-infected patients with CD4 T cells above 450/mm (2012) (0)
Epilogue: Immunological Monitoring of HIV-1 Infection / Subject Index (1992) (0)
Title Page / Contents / Foreword / Preface (1992) (0)
Transfer of Human CD 4 1 T Lymphocytes Producing Beta Interferon in Hu-PBL-SCID Mice Controls Human Immunodeficiency Virus Infection (1999) (0)
Control of vaccinia virus skin lesions by long-term-maintained IFN-γ+TNF-α+ effector/memory CD4+ lymphocytes in humans (2021) (0)
HIV-Natural Variants Responses Against Poorly Immunogenic Determines Selective Cross-Reactive Immune In Vivo Priming Of HIV-Specific CTLs (2002) (0)
Female Doctors Today: The Future of Medicine? (2014) (0)
EBV Dictates Lower Tumor Neoepitopes Scores and Intra-Tumoral Repertoire Diversity in NHL from Immuno-Compromized Patients (2022) (0)
Immune control of HIV reservoirs and cure therapeutic strategies (2015) (0)
P16-11. HLA-B57/5801 induces preferential CD27 expression on HIV-Gag but not Nef specific central memory CD8+T cells controlling HIV (2009) (0)
T cell crossreactivity of gag and nef epitopes derived from european and brazilian HIV-1 strains among brazilian and french HIV-1 infected patients (2008) (0)
Immune responses and latent tissue reservoirs during the course of HIV-1 infection. (2013) (0)
Therapeutic vaccines for chronic infections : Immunotherapy (2004) (0)
EFFECT INHIBITEUR DES LYMPHOCYTES CD8 + CD57 + SUR LA CYTOTOXICITE A MEDIATION CELLULAIRE : CARACTERISATION D'UN FACTEUR SUPPRESSEUR (1991) (0)
122 Interplay Between HIV Replication and MicroRNAs (2011) (0)
PersistentChronic Inflammation and Infection byChikungunya Arthritogenic Alphavirus in Spite of a Robust Host Immune Response (2010) (0)
Cellular immune responses and changes in VL after a Dendritic Cells (DC)-based therapeutic vaccine in cART treated chronic HIV-infected patients with CD4 T cells above 450/mm (2012) (0)
Phenotype and function of peripheral blood and bone marrow T-cell colonies: identification of DC3-, 4-, 8-autoreactive T cells. (1989) (0)
HIV Infection, Immune-Based Interventions for (2015) (0)
CD4 T helper lymphocytes and antigen presenting cells in the physiopathology of AIDS. (1998) (0)
Progesterone-mediated immunosuppression in pregnancy I. Progesterone receptors in human lymphocytes (1989) (0)
Accumulation of follicular T Helper (Tfh) cells, despite preferential infection, allows establishment of a large and unexpected viral reservoir during HIV infection (2016) (0)
An immunological score for prediction of acute rejection of heart transplants. (1995) (0)
Transcutaneous immunization by targeting (2005) (0)
The Frequency of Cytomegalovirus (CMV)-Specific CD8+ T Cells Distinguishes CMV Clinical Outcomes Following Hematopoietic Allogeneic Stem Cell Transplant: A Prospective Multicentre Cohort Study (2015) (0)
P.406 Weak and delayed hepatitis C virus-specific T cell responses during acute hepatitis C in HIV-infected patients (2006) (0)
Response to Adjuvanted Monovalent Influenza A (H1N1)v Vaccine In Allogeneic Hematopoietic Stem Cell Transplant Recipients (2010) (0)
P.408 Safety and efficacy of a 24-week course of pegylated interferon α-2a and ribavirin for the treatment of acute HCV infection in HIV positive patients (2006) (0)
Antigen-specific CD8 cells and MHC-peptide tetramers (2001) (0)
Expansion of Human Cytomegalovirus (HCMV) Immediate-Early 1-Speciﬁc CD8 (cid:1) T Cells and Control of HCMV Replication after Allogeneic Stem Cell Transplantation (cid:1) (2008) (0)
Conventional Dendritic Cells and Slan+ Monocytes During HIV-2 Infection (2020) (0)
Alvéolites lymphocytaires et infection HIV (1990) (0)
Production in Women a Cell Levels of IRF5 Drive Higher IFN-Sex Differences in Plasmacytoid Dendritic (2015) (0)
ResponseAlphavirus in Spite of a Robust Host Immune Infection by Chikungunya Arthritogenic Persistent Chronic Inflammation and (2010) (0)
Influence of the ARV regimen on the early changes in plasma HIV RNA and immune activation at initiation of antiretroviral therapy in naïve HIV-1-infected patients. (2020) (0)
Serum neutralization of SARS coronavirus 2 Omicron sublineages BA.1 and BA.2 and cellular immune responses 3 months after booster vaccination (2022) (0)
[Cytotoxic response against human immunodeficiency virus (HIV): control with suppressor factor]. (1992) (0)
[Legionnaires' disease in Hodgkin's disease]. (1982) (0)
[Pancreatic cancer revealed by hyperosmolar coma: report on two cases (author's transl)]. (1981) (0)
Direct Quantiﬁcation of Cell-Associated HIV DNA in Isolated Rectal and Blood Memory CD4 T Cells Revealed Their Similar and Low Infection Levels in Long-Term Treated HIV-Infected Patients (2018) (0)
Peripheral Blood Lymphocytes and Skin with HIVgp160 in SCID-hu Mice Coengrafted Primary Th1 Cell Immunization Against (1998) (0)
[461] ACUTE HEPATITIS C INFECTION IN HIV-INFECTED PATIENTS: LOW RATE OF SPONTANEOUS CLEARANCE AND WEAK HEPATITIS C VIRUS-SPECIFIC T CELL RESPONSES (2007) (0)
CD34+ selection and age autologous transplantation in adults with multiple myeloma: role of ex-vivo Evidence for naive T-cell repopulation despite thymus irradiation after (2013) (0)
O646 - Major histocompatibility gene frequencies in long term asymptomatic (LTA) HIV patients in France (1996) (0)
Reconstitution immune sous traitements antirétroviraux de l'infection par le VIH (1999) (0)
T cell crossreactivity of gag and nef epitopes derived from brazilian and europea HIV-1 strains among brazilian and french HIV-1 infected patients (2008) (0)
[Risk of smallpox, vaccination, bioterrorism]. (2005) (0)
Immunodeficiency in HIV Infection and AIDS EC/FERS/MRC Workshop on Immunodeficiency in HIV-1 Infections, Windsor, Surrey, May 3-4, 1991 Immunodeficiency in HIV Infection and AIDS Editors G. Janossy, London (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Brigitte Autran?

Brigitte Autran is affiliated with the following schools:

Brigitte Autran's Academic­Influence.com Rankings

Brigitte Autran's Degrees

Why Is Brigitte Autran Influential?

Brigitte Autran's Published Works

Published Works

What Schools Are Affiliated With Brigitte Autran?

Brigitte Autran's AcademicInfluence.com Rankings